drugset / Trial / NCT02436824

A Study of a Topical Patch (AB001) in Patients With Chronic Low Back Pain

NCT02436824 ↗

Phase 2 Completed 146 enrolled Frontier Biotechnologies Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objectives of this study are to examine the safety, tolerability, and efficacy of repeated topical administration of AB001 topical patches for the treatment of chronic low back pain.

Timeline

Start
2015-04
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AB001 Other / unclassified 2 unknown Topical

Indications